WCN24-1486 ATYPICAL HEMOLYTIC SYNDROME INDUCED BY PEMBROLIZUMAB. MANAGEMENT AND OUTCOMES

Saved in:
Bibliographic Details
Main Authors: Natallia Maroz, Ashantice Higgins, John Harcha, Kelsey Marshall, Derek Jernigan
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Kidney International Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024924002328
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849692948790247424
author Natallia Maroz
Ashantice Higgins
John Harcha
Kelsey Marshall
Derek Jernigan
author_facet Natallia Maroz
Ashantice Higgins
John Harcha
Kelsey Marshall
Derek Jernigan
author_sort Natallia Maroz
collection DOAJ
format Article
id doaj-art-97f61cedf9ba4905bb6aa9b5dbd05c24
institution DOAJ
issn 2468-0249
language English
publishDate 2024-04-01
publisher Elsevier
record_format Article
series Kidney International Reports
spelling doaj-art-97f61cedf9ba4905bb6aa9b5dbd05c242025-08-20T03:20:34ZengElsevierKidney International Reports2468-02492024-04-0194S66S6710.1016/j.ekir.2024.02.143WCN24-1486 ATYPICAL HEMOLYTIC SYNDROME INDUCED BY PEMBROLIZUMAB. MANAGEMENT AND OUTCOMESNatallia Maroz0Ashantice Higgins1John Harcha2Kelsey Marshall3Derek Jernigan4Dayton, Internal Medicine/Nephrology, United StatesInternal Medicine/Hematology and Oncology, Wright State University/Kettering Health, DaytonInternal Medicine/Hematology and Oncology, Kettering Health, DaytonInternal Medicine/Hematology and Oncology, Kettering Health, DaytonInternal Medicine, Kettering Health, Dayton,http://www.sciencedirect.com/science/article/pii/S2468024924002328
spellingShingle Natallia Maroz
Ashantice Higgins
John Harcha
Kelsey Marshall
Derek Jernigan
WCN24-1486 ATYPICAL HEMOLYTIC SYNDROME INDUCED BY PEMBROLIZUMAB. MANAGEMENT AND OUTCOMES
Kidney International Reports
title WCN24-1486 ATYPICAL HEMOLYTIC SYNDROME INDUCED BY PEMBROLIZUMAB. MANAGEMENT AND OUTCOMES
title_full WCN24-1486 ATYPICAL HEMOLYTIC SYNDROME INDUCED BY PEMBROLIZUMAB. MANAGEMENT AND OUTCOMES
title_fullStr WCN24-1486 ATYPICAL HEMOLYTIC SYNDROME INDUCED BY PEMBROLIZUMAB. MANAGEMENT AND OUTCOMES
title_full_unstemmed WCN24-1486 ATYPICAL HEMOLYTIC SYNDROME INDUCED BY PEMBROLIZUMAB. MANAGEMENT AND OUTCOMES
title_short WCN24-1486 ATYPICAL HEMOLYTIC SYNDROME INDUCED BY PEMBROLIZUMAB. MANAGEMENT AND OUTCOMES
title_sort wcn24 1486 atypical hemolytic syndrome induced by pembrolizumab management and outcomes
url http://www.sciencedirect.com/science/article/pii/S2468024924002328
work_keys_str_mv AT natalliamaroz wcn241486atypicalhemolyticsyndromeinducedbypembrolizumabmanagementandoutcomes
AT ashanticehiggins wcn241486atypicalhemolyticsyndromeinducedbypembrolizumabmanagementandoutcomes
AT johnharcha wcn241486atypicalhemolyticsyndromeinducedbypembrolizumabmanagementandoutcomes
AT kelseymarshall wcn241486atypicalhemolyticsyndromeinducedbypembrolizumabmanagementandoutcomes
AT derekjernigan wcn241486atypicalhemolyticsyndromeinducedbypembrolizumabmanagementandoutcomes